Avita Pharmacy is authorized to dispense EGRIFTA®.

Egrifta® -- Because if it’s bothering you, it’s worth talking about.

EGRIFTA® is the first FDA-approved, self-injectable medicine to reduce HIV-related excess abdominal (belly) fat in patients with lipodystrophy, a condition in which fat builds up in some places and goes away in others. “As a pharmacy that stands committed to offering specialized services to our patients, we feel that the addition of EGRIFTA® will benefit patients affected with less than desirable side effects of HIV/AIDS,” said Jerry Purcell, Founder of Avita Drugs. “For many patients, excess abdominal belly fat is distressing. We look forward to having the opportunity to dispense transformative, effective medicines that can change a patient’s life. EGRIFTA® (tesamorelin) is distributed by EMD Serono, Inc., and is a registered trademark of Theratechnologies, Inc. Click here to learn more about Egrifta®.